Phacet develops software for pharmaceutical compounding and patient care.
Founded in 2024 in Overijssel, Netherlands, Phacet develops digital tools for pharmacological and pharmaceutical care. Its open-source Compound Server manages pharmaceutical compounding and dispensing, integrates with prescribing systems, and can connect to robotic systems. Phacet also maintains a drug dosing knowledge base focused on obesity and post-bariatric surgery. In September 2024, it raised EUR 4 million in seed funding from Motier Ventures, Aglaé Ventures, Emblem, Origins Capital Partners, and others.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in